[go: up one dir, main page]

BRPI0907913A2 - Ciclopentanos substituídos tendo atividade de prostaglandina - Google Patents

Ciclopentanos substituídos tendo atividade de prostaglandina

Info

Publication number
BRPI0907913A2
BRPI0907913A2 BRPI0907913-0A BRPI0907913A BRPI0907913A2 BR PI0907913 A2 BRPI0907913 A2 BR PI0907913A2 BR PI0907913 A BRPI0907913 A BR PI0907913A BR PI0907913 A2 BRPI0907913 A2 BR PI0907913A2
Authority
BR
Brazil
Prior art keywords
substituted cyclopentanes
prostaglandin activity
prostaglandin
activity
cyclopentanes
Prior art date
Application number
BRPI0907913-0A
Other languages
English (en)
Inventor
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0907913A2 publication Critical patent/BRPI0907913A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0907913-0A 2008-02-05 2009-02-03 Ciclopentanos substituídos tendo atividade de prostaglandina BRPI0907913A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2617908P 2008-02-05 2008-02-05
US12/363,996 US8455547B2 (en) 2008-02-05 2009-02-02 Substituted cyclopentanes having prostaglandin activity
PCT/US2009/032943 WO2009100057A1 (en) 2008-02-05 2009-02-03 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
BRPI0907913A2 true BRPI0907913A2 (pt) 2015-07-28

Family

ID=40932327

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907913-0A BRPI0907913A2 (pt) 2008-02-05 2009-02-03 Ciclopentanos substituídos tendo atividade de prostaglandina

Country Status (12)

Country Link
US (1) US8455547B2 (pt)
EP (2) EP2245005A1 (pt)
JP (1) JP5566912B2 (pt)
KR (1) KR20100119787A (pt)
CN (1) CN101959854A (pt)
AU (1) AU2009212570B2 (pt)
BR (1) BRPI0907913A2 (pt)
CA (1) CA2713958A1 (pt)
IL (1) IL207354A0 (pt)
MX (1) MX2010008589A (pt)
RU (1) RU2505530C2 (pt)
WO (1) WO2009100057A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2418592C1 (ru) * 2010-04-19 2011-05-20 Геннадий Васильевич Порядин Способ лечения артериальной гипертонии
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384865A (en) * 1971-06-11 1975-02-26 Searle & Co Stereospecific reduction of 9,15-dioxo prostanglandins
JPS55133354A (en) * 1979-04-02 1980-10-17 Upjohn Co Prostaglandin derivatives
US4259516A (en) * 1979-04-02 1981-03-31 The Upjohn Company 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds
US4675182A (en) 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
DE3304864A1 (de) * 1983-02-12 1984-08-16 Bayer Ag, 5090 Leverkusen Adsorbate von prostaglandinen
DE69823852T2 (de) 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
SE9702681D0 (sv) * 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
MXPA05008431A (es) * 2003-02-11 2005-10-19 Allergan Inc Derivados de acido 10,10-dialquil prostanoico como agentes para reducir la presion intraocular.
TWI348386B (en) 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
SI1759702T1 (sl) 2004-05-26 2009-06-30 Bayardo Arturo Jimenez Postopek pripravljanja oftalmiäśne raztopine latanoprosta in tako proizvedena raztopina
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
GB0524103D0 (en) 2005-11-26 2006-01-04 Medical Res Council Healing
US7476755B2 (en) * 2006-05-04 2009-01-13 Allergan, Inc. Therapeutic compounds
WO2007149312A2 (en) 2006-06-16 2007-12-27 The Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph

Also Published As

Publication number Publication date
CA2713958A1 (en) 2009-08-13
RU2505530C2 (ru) 2014-01-27
US20090197962A1 (en) 2009-08-06
CN101959854A (zh) 2011-01-26
AU2009212570A1 (en) 2009-08-13
IL207354A0 (en) 2010-12-30
AU2009212570B2 (en) 2014-04-10
WO2009100057A1 (en) 2009-08-13
EP2487153A1 (en) 2012-08-15
MX2010008589A (es) 2010-08-23
EP2245005A1 (en) 2010-11-03
US8455547B2 (en) 2013-06-04
KR20100119787A (ko) 2010-11-10
RU2010135795A (ru) 2012-03-20
JP2011511081A (ja) 2011-04-07
JP5566912B2 (ja) 2014-08-06

Similar Documents

Publication Publication Date Title
FI20085488A0 (fi) Älykäs hammasharjamonitorointilaite
BRPI0920835A2 (pt) escova de dentes
DE112009004699A5 (de) Elektrochirurgisches System
BRPI0822884A2 (pt) Escova de dentes
BRPI0816314A2 (pt) Método de conversão
BRPI0822906A2 (pt) Escova de dentes
BRPI0810702A2 (pt) Catalisador
BRPI0815246A2 (pt) Composição de catalisador
BRPI0918344A2 (pt) composição catalítica
BRPI0816315A2 (pt) Método de conversão
BRPI0921038A2 (pt) ácido naftilacéticos
BRPI0907108A2 (pt) escova de dentes.
BRPI0918134A2 (pt) derivado de prostaglandina i2
EP2242580A4 (en) ZIEGLER-NATTA CATALYST
FI20086154A0 (fi) Katalyyttirakenne
FI9107U1 (fi) Houkutin
BRPI0818902A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
DK2245463T3 (da) Diagnostisk fremgangsmåde
BRPI0910931A2 (pt) ciclopentanos substituídos terapêuticos
BRPI0819707A2 (pt) Ciclopentanos substituídas tendo atividade de prostaglandina
EP2273131A4 (en) ENCODED
BRPI0907913A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
FI20096202A0 (fi) Biologinen regeneraatti
IT1390861B1 (it) Composti ad attività antimalarica
SE0801905L (sv) Katalysatorer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.